GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Durect Corp (FRA:DC8A) » Definitions » Balance Sheet Cash And Cash Equivalents

Durect (FRA:DC8A) Balance Sheet Cash And Cash Equivalents


View and export this data going back to . Start your Free Trial

What is Durect Balance Sheet Cash And Cash Equivalents?

Please go to this page to see Cash And Cash Equivalents for non-financial companies.


Durect (FRA:DC8A) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Durect Corp (FRA:DC8A) » Definitions » Balance Sheet Cash And Cash Equivalents
Traded in Other Exchanges
Address
10260 Bubb Road, Cupertino, CA, USA, 95014
Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories which include new chemical entities and proprietary pharmaceutical programs. The company's pipeline products consist of DUR-928, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan, and other countries, of which key revenue is derived from the Europe .